Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,618 | -171,298 | -129,974 | -78,823 | -33,940 |
| Depreciation Amortization | -593 | -4,156 | -3,570 | -2,869 | -1,681 |
| Accounts receivable | -839 | -17,205 | -28,382 | -14,375 | -1,128 |
| Other Working Capital | 8,597 | -20,004 | -12,541 | -11,471 | -10,415 |
| Other Operating Activity | 8,507 | 41,797 | 47,086 | 27,204 | 6,422 |
| Operating Cash Flow | $-44,946 | $-170,866 | $-127,381 | $-80,334 | $-40,742 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,791 | 64,967 | 38,853 | 77,777 | 29,155 |
| PPE Investments | N/A | -339 | -339 | -142 | -91 |
| Purchase Sale Intangibles | N/A | -7,860 | -5,860 | N/A | N/A |
| Other Investing Activity | 0 | -7,860 | -5,860 | 0 | 0 |
| Investing Cash Flow | $27,791 | $56,768 | $32,654 | $77,635 | $29,064 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 98,917 | 100,327 | N/A | N/A |
| Common Stock Issued | 62 | 5,681 | 3,901 | 3,422 | 725 |
| Other Financing Activity | 97 | 0 | -761 | 0 | 0 |
| Financing Cash Flow | $159 | $104,598 | $103,467 | $3,422 | $725 |
| Beginning Cash Position | 41,317 | 50,817 | 50,817 | 50,817 | 50,817 |
| End Cash Position | 24,321 | 41,317 | 59,557 | 51,540 | 39,864 |
| Net Cash Flow | $-16,996 | $-9,500 | $8,740 | $723 | $-10,953 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,946 | -170,866 | -127,381 | -80,334 | -40,742 |
| Capital Expenditure | N/A | -339 | -339 | -142 | -91 |
| Free Cash Flow | -44,946 | -171,205 | -127,720 | -80,476 | -40,833 |